Results 81 to 90 of about 707 (123)
REACTIVATION OF CHAGAS DISEASE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT: CASE SERIES
Brazilian Journal of Infectious DiseasesChagas disease, caused by Trypanosoma cruzi, remains an important public health problem in the Americas. Although the most prevalent chronic form is cardiac, central nervous system reactivation is rare but severe, particularly in immunosuppressed ...
Clara dos Reis Aguiar +4 more
doaj +1 more source
Benznidazole for Chronic Chagas’ Cardiomyopathy
New England Journal of Medicine, 2016 Hamers, Raph L. +2 more
openaire +6 more sources
Chagas, a Cardiomyopathy Emerging from Obscurity [PDF]
European Journal of Heart Failure, 2015 Westenbrink, B. Daan, Kingma, J. Herre
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy
International Journal of Cardiology, 2013Chagas cardiomyopathy and ischemic heart disease (IHD) are frequent causes of chronic systolic heart failure (CHF) in areas where the former is endemic. Nonetheless, a specific comparison of outcome and role of etiology of CHF failure has not been performed in patients with both conditions.Two-hundred twenty two patients with Chagas cardiomyopathy and ...
Augusto Cardinalli-Neto +1 more
exaly +3 more sources
Dimensions of Critical Care Nursing, 2023
Abstract Chagas disease is a prominent neglected tropical disease endemic to many countries in Latin America. Cardiomyopathy is the most serious manifestation due to the severity and complications of heart failure. As a result of expanded immigration and globalization, there is an increased number of patients with Chagas cardiomyopathy who are being ...
Ariana, Jimenez, Elizabeth J, Winokur
openaire +2 more sources
Abstract Chagas disease is a prominent neglected tropical disease endemic to many countries in Latin America. Cardiomyopathy is the most serious manifestation due to the severity and complications of heart failure. As a result of expanded immigration and globalization, there is an increased number of patients with Chagas cardiomyopathy who are being ...
Ariana, Jimenez, Elizabeth J, Winokur
openaire +2 more sources
Chagas Disease: Chronic Chagas Cardiomyopathy
Current Problems in Cardiology, 2021Chagas disease (CD) is a tropical vector-borne infection caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), also known as American Trypanosomiasis. It is considered endemic in all South and Central America and in this past decades its becoming a burden particularly in the United States and Europe due to human migration. The vast majority of
Natalia Giraldo Echavarría +4 more
openaire +2 more sources
Chagas cardiomyopathy and captopril
European Heart Journal, 1992Chagas disease is a leading cause of heart failure in Latin America. Sudden death occurs in approximately 40% of patients with heart failure due to Chagas disease. We report a single blind, cross-over trial of prolonged treatment with captopril and placebo in 18 Chagas disease patients with class IV NYHA heart failure.
Roberti, Roberto Rinaldo UNIFESP +6 more
openaire +3 more sources
Heart transplantation for chagas' cardiomyopathy
The Annals of Thoracic Surgery, 1995We present 2 patients who underwent orthotopic heart transplantation for end-stage Chagas' cardiomyopathy. Despite immunosuppressive therapy, postoperative prophylaxis with nifurtimox appeared to prevent Trypanosoma cruzi reactivation. Neither patient has shown signs of Chagas' myocarditis, and both are clinically well 12 and 72 months after ...
C, Blanche +5 more
openaire +2 more sources
2018
Abstract Chagas’ cardiomyopathy is a major complication emerging from Trypanosoma cruzi infection, appearing in up to 30% of individuals with positive serology and being the principal cause of death from heart failure in some areas of South America.
Carlos Eduardo Rochitte +1 more
openaire +1 more source
Abstract Chagas’ cardiomyopathy is a major complication emerging from Trypanosoma cruzi infection, appearing in up to 30% of individuals with positive serology and being the principal cause of death from heart failure in some areas of South America.
Carlos Eduardo Rochitte +1 more
openaire +1 more source
An update on the management of Chagas cardiomyopathy
Expert Review of Anti-infective Therapy, 2007Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, infects nearly 18 million people in Latin America and mainly affects the heart, causing heart failure, arrhythmias, heart block, thromboembolism, stroke and death. In this review, the clinical diagnosis and management of Chagas cardiomyopathy are discussed.
Manoel O C, Rocha +2 more
openaire +2 more sources